Article Versions Notes

Sheetz T, Mills J, Tessari A, Pawlikowski M, Braddom AE, Posid T, Zynger DL, James C, Embrione V, Parbhoo K, et al. NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers. 2020; 12(7):1861. https://doi.org/10.3390/cancers12071861

Sheetz, Tyler, Joseph Mills, Anna Tessari, Megan Pawlikowski, Ashley E. Braddom, Tasha Posid, Debra L. Zynger, Cindy James, Valerio Embrione, Kareesma Parbhoo, and et al. 2020. "NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs" Cancers 12, no. 7: 1861. https://doi.org/10.3390/cancers12071861

Sheetz, T., Mills, J., Tessari, A., Pawlikowski, M., Braddom, A. E., Posid, T., Zynger, D. L., James, C., Embrione, V., Parbhoo, K., Foray, C., Coppola, V., Croce, C. M., & Palmieri, D. (2020). NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers, 12(7), 1861. https://doi.org/10.3390/cancers12071861